TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive Also in this 8-page issue: NIH opens 240-bed Hatfield Clinical Research Center. September 24, 2004